Here, we found that circulating levels of 3-hydroxydecanoate were increased in patients with T2D and that administration of 3-hydroxydecanoate to mice increased fasting serum insulin, induced tissue inflammation, and immune cell infiltration in iWAT and eWAT. The gene discussed is INS; the disease is type 2 diabetes mellitus.